Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials - Lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Article

关键词: BREAST-CANCER;    LINE CHARACTERISTICS;    BLACK PATIENTS;    TAMOXIFEN;    NEPHROSCLEROSIS;    REPRESENTATION;    PARTICIPANTS;    PROGRESSION;    RATIONALE;    DIAGNOSIS;   

DOI  :  10.1161/CIRCULATIONAHA.105.540443

来源: SCIE

【 授权许可】

Free